Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-754-7 | CAS number: 693-57-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
A toxicokinetic study has not been performed but a toxicokinetic assessment has been prepared
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 25
- Absorption rate - inhalation (%):
- 100
Additional information
Introduction
Physico-chemical properties and the results of in vitro studies and acute and repeat dose toxicity studies with animals for 12-aminododecanoic acid (CAS 693-57-2) have been used to determine a toxicokinetic profile.
Physicochemical properties
The substance 12-aminododecanoic acid is a white powder and has the molecular formula C12O2NH27 with a molecular weight of 217.1 g/mol. It is relatively soluble, the maximum solubility being 137 mg/L at 25°C, with a log Pow value of -0.607 at 25°C (Walker and Mullee, 2007). Aminododecanoic acid contains a carboxylic acid and an amino group and is zwitterionic in nature, with a neutral pH, and a pKa and pKb of 4.8 and 10.7 respectively.
Absorption
Oral absorption
Oral absorption was experimentally evident from pathology manifesting in the OECD 422 study conducted by Dhinsa and Petrie (2007). Nothing could be inferred about the extent of oral absorption however.
Estimation of the extent of mammalian oral absorption is made on basis of similarity to fatty acids which are readily absorbed through incorporation into micelles and absorption via the lymphatic system, and the physical chemical properties of the substance which allow it to be taken up through the mass uptake of water and/or aqueous pores across membranes. The physical chemical properties are comparable with those delineated by ECHA (2012) for such absorption processes across the gastrointestinal tract (sufficiently water soluble given anticipated exposure: 137 mg/L; small MW of up to around 200 g/mol, a Pow between -1 and <4).
A value of 100% is assumed oral absorption for all mammalian species, where present at levels comparable to those that might be experienced under occupational exposure scenarios.
Dermal absorption
Estimation of mammalian dermal absorption is made in accordance with principles adopted within the EFSA guidance on estimating dermal absorption of pesticide active substances (EFSA, 2012). On this basis, dermal absorption is estimated at 25% for undiluted material. This is considered an appropriate estimate because values of ca 25% were obtained in vivo in rats for substances with a MW of ca. 271 -288. These were very conservative estimates in themselves given one was based on a dilution and high skin residues were included in the other. In addition no correction for human skin was made. Therefore, taking into account the slightly smaller molecular weight for 12-aminododecanoic acid of 217.1 g/mol, 25% is considered a reasonable estimation of the human dermal penetration.
Inhalation
In the absence of any other data, absorption of material reaching the alveoli is estimated at 100%.
Distribution
Distribution is estimated to be wide throughout the body. The OECD 422 toxicity study (Dhinsa and Petrie, 2007) shows only relevant toxicology in red blood cells and the kidney. This may suggest some preferential partitioning into RBC membranes. The kidney is an organ of excretion and total exposure of kidneys to the test material might reasonably be expected to be greater than other organs.
Metabolism
Not Known. The material was readily biodegradable in aerobic sewage sludge (Kitano, 1985). At low doses metabolism by gut flora may perform the majority of metabolism prior to absorption.
Elimination
Not known. Given the molecule is of low molecular weight (<300 g/mol, above which biliary excretion tends to predominate) and appears readily biodegradable (achieving smaller fragments), elimination is estimated to be via the kidney given the pathology observed in the OECD 422 study (Dhinsa and Petrie, 2007). The pathology consisted of a) groups of basophilic tubules; b) tubular dilatation; c) hypertrophy collecting duct epithelium; d) hyperplasia pelvic/papillary epithelium. The same lesions (and others) were observed also in animals of both sexes at 1000 mg/kg at termination, and most of them (i.e. a), c) and d)) were still observable in recovery animals, thus suggesting that the damage was permanent. In contrast there was no pathology observed in the liver.
It is not know how rapid excretion would be.
Conclusion
The substance 12-aminododecanoic acid is expected to be readily absorbed after ingestion, and absorption is expected to be 100% at typical occupational exposure levels. Dermal absorption is estimated at 25%, whilst inhalation absorption is estimated at 100%. Elimination is expected to be predominantly via the urine.
References
Author (year) |
Title Source (where different from company) Company, Report No. GLP or GEP status (where relevant) Published or Unpublished |
ECHA (2012) |
Guidance on information requirements and chemical safety assessment Chapter R.7c: Endpoint specific guidance. www.echa.europa.eu Not GLP Published |
Walker, J. A. and Mullee, D. M. (2007) |
12-Aminododecanoic acid: Determination of General Physicochemical Properties. Safepharm Laboratories Limited, Derby, UK Ube Industries Ltd, Report number: 1456/0091 GLP Unpublished |
Dhinsa,N. K. and Petrie, A. J. (2007) |
12-Aminododecanoic Acid: Oral (Gavage) Combined Repeat Dose Toxicity Study with Reproduction/Developmental Toxicity Screening Test in the Rat (OECD 422 1996 with Recovery Groups). Safepharm Laboratories Limited, Derby, UK Ube Industries Ltd, Report number: 1456/0083 GLP Unpublished |
EFSA (2012) |
SCIENTIFIC OPINION: Guidance on Dermal AbsorptionfromEFSA Panel on Plant Protection Products and their Residues (PPR). European Food Safety Authority (EFSA), Parma, Italy. EFSA Journal2012;10(4):2665 Not GLP Published |
Kitani, H. (1985) |
The Biodegradablity Test of S-153. Chemical Biotesting Center, Chemicals Inspection & Testing Institute, Japan. Ube Industries LTD, Report number: 33314 Not GLP Unpublished |
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.